TruLab, Real-Time Technology for Clinical Trial Oversight

What if you could know when mistakes happen in your clinical trial in real time? And what if those mistakes could be remedied all while the patient is still on site? This isn’t just every sponsor’s pipe dream – it’s already happening in hundreds of clinical trial sites worldwide. To learn how TruLab’s clinical trial oversight technology is helping top pharma and biotechs ensure protocol compliance, protect data integrity, and expedite study timelines, visit www.trulab.com/monitoring.

TruLab was proud to join this impressive group in support of The Leukemia & Lymphoma Society. Together, we can help find a cure for blood cancers and empower patients with the resources they need along the way.

August is Spinal Muscular Atrophy (SMA) month. SMA is a progressive neurodegenerative disease that affects the motor nerve cells in the spinal cord and impacts the muscles used for activities such as breathing, eating, crawling, and walking. Several new FDA-approved therapies exist for the treatment of SMA. #SMA #SMAawarenessmonth #FDA

When precious samples from a pediatric rare disease study are left out on the loading dock over the weekend, who loses the most? Well, researchers and the science at large, certainly. But more importantly, it's the patient. And these types of occurrences are far more common than you'd think, as Ray Reilly explains. Patients deserve a better system of making sure these types of mistakes never happen in the first place.

It’s no secret that front line research staff at clinical sites today are facing significant challenges. They’re overworked due to chronic understaffing and high turnover, and overwhelmed with increasingly complex studies. Let’s give them the tools to make their jobs easier.

We know that trials prioritizing the patient experience are nearly 20% more likely to end with positive results, so why do so many studies continue to leave patients feeling untaken care of? According to TruLab’s Jim Wahl, protocol deviations have a lot to do with this.

"There are some things you learn best in calm, and some in storm," the great Willa Cather once wrote. And this certainly proved to be the case when COVID-19 upended clinical trial operations and forced the industry to find innovative ways to move forward. Let's keep that momentum going.

💡 Did you know? The FDA promotes capturing source data in electronic form because it: ✅ Eliminates unnecessary duplication of data ✅ Reduces the possibility for transcription errors ✅ Encourages entering source data during a subject’s visit ✅ Eliminates transcription of source data prior to entry into an eCRF ✅ Facilitates remote monitoring of data ✅ Promotes real-time access for data review ✅ Facilitates the collection of accurate and complete data Did you also know that TruLab enables studies to do exactly that WHILE SERVING as the original data source for both sites and sponsors?

Embrace the future of supply chain certainty with Marken INsight, the ultimate solution for real-time biological sample management and monitoring.   Powered by TruLab, Real-Time Technology for Clinical Trial Oversight, this cutting-edge, sample-level tracking logistics solution offers a seamless, paperless value chain, delivering real-time alerts, end-to-end visibility and proactive monitoring. With Marken Insight, we go beyond standard sample management and tracking, providing speed and precision at the tube-level for clients and key stakeholders throughout the pharmaceutical journey.   Don’t settle for delayed critical insights - Gain more visibility into “the black box” than ever before.   Contact our experts to learn more: [email protected]   #Marken #MarkenINsight #BiologicalSamples #ClinicalTrials #ClinicalTrial #BiologicalSampleTracking #GlobalNetwork #Healthcare

Upwards of 20% of samples are unusable due to: 👉🏽 Out of window collections 👉🏽 Sample mishandling 👉🏽 Other errors that originate at the clinical sites And if peaks and troughs are not observed in PK profiles following sample analysis, sample switching likely occurred. 🙌 Solution: End-to-end sample tracking with real-time protocol monitoring can prevent these errors and improve the quality of research data.